Maud A. Van Der Kleij

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Impact of Abiraterone Therapeutic Drug Monitoring on Cortisol as a Surrogate Biomarker of CYP17 Inhibition in Metastatic Prostate Cancer Treatment.

Impact of Abiraterone Therapeutic Drug Monitoring on Cortisol as a Surrogate Biomarker of CYP17 Inhibition in Metastatic Prostate Cancer Treatment.

Journal: Therapeutic drug monitoring

Published: July 02, 2025

Therapeutic Drug Monitoring of Oral Targeted Anticancer Drugs: Achievements, Experiences, Challenges, and the Path Forward.

Therapeutic Drug Monitoring of Oral Targeted Anticancer Drugs: Achievements, Experiences, Challenges, and the Path Forward.

Journal: Therapeutic drug monitoring

Published: May 23, 2025

Assessing Safety of the Transition to Generic Imatinib in Patients with Gastrointestinal Stromal Tumours.

Assessing Safety of the Transition to Generic Imatinib in Patients with Gastrointestinal Stromal Tumours.

Journal: Oncology and therapy

Published: April 23, 2025

Imatinib Desensitization After a Type IV Hypersensitivity Reaction in a Gastrointestinal Stromal Tumor Patient-A Case Report.

Imatinib Desensitization After a Type IV Hypersensitivity Reaction in a Gastrointestinal Stromal Tumor Patient-A Case Report.

Journal: Cancer reports (Hoboken, N.J.)

Published: February 10, 2025

Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patients.

Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patients.

Journal: British journal of cancer

Published: September 27, 2024

Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort.

Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort.

Journal: Clinical pharmacokinetics

Published: June 24, 2024

Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails.

Therapeutic Drug Monitoring of Oral Oncology Drugs: Finding the Right Nails.

Journal: Clinical pharmacology and therapeutics

Published: April 19, 2024

Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.

Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology - an analysis of the closed cohorts of a multicentre prospective study.

Journal: British journal of cancer

Published: April 15, 2024

Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.

Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.

Journal: Clinical pharmacokinetics

Published: July 24, 2023

Design and statistics of pharmacokinetic drug-drug, herb-drug, and food-drug interaction studies in oncology patients.

Design and statistics of pharmacokinetic drug-drug, herb-drug, and food-drug interaction studies in oncology patients.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 01, 2023

Showing 1-10 of 10

Last Updated: 09/26/2026